Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers

Oral Oncol. 2022 Apr:127:105824. doi: 10.1016/j.oraloncology.2022.105824. Epub 2022 Mar 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Head and Neck Neoplasms* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab